Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII

Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H (2000)
JOURNAL OF BIOLOGICAL CHEMISTRY 275(42): 33008-33013.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Abstract
The effects of plasma proteins on controlling the activity of matrix metalloproteinases (MMPs, matrixins) have been the focus of numerous studies, although only a few have examined the influence of matrixins on plasma proteins. Recently, it has been shown that MMPs may play a role in the degradation of fibrin, We have now investigated the role of collagenase-a (MMP-8), macrophage elastase (MMP-12), collagenase-3 (MMP-13), and membrane type 1-matrix metalloproteinase (MT1-MMP, MMMP-14) in the degradation of fibrinogen and Factor XII of the plasma clotting system. Our data demonstrate that the catalytic domains of MMP-8, MMP-12, MMP-13, and MMP-14 can proteolytically process fibrinogen and, with the exception of MMP-8, also inactivate Factor XII (Hageman factor). We have identified the amino termini of the major protein fragments. Cleavage of fibrinogen occurred in all chains and resulted in significantly impaired clotting. Moreover, rapid proteolytic inactivation of Factor XII (Hageman factor) by MMP-18, MMP-13, and MMP-14 was noted. These results support the hypothesis of an impaired thrombolytic potential of MMP-degraded Factor MI in vivo. MMP-induced degradation of fibrinogen supports a plasmin-independent fibrinolysis mechanism. Consequently, degradation of these proteins may be important in inflammation, atherosclerosis, and angiogenesis, all of which are known to be influenced by MMP activity.
Publishing Year
ISSN
PUB-ID

Cite this

Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 2000;275(42):33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., & Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), 33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., and Tschesche, H. (2000). Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY 275, 33008-33013.
Hiller, O., et al., 2000. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(42), p 33008-33013.
O. Hiller, et al., “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 275, 2000, pp. 33008-33013.
Hiller, O., Lichte, A., Oberpichler, A., Kocourek, A., Tschesche, H.: Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. JOURNAL OF BIOLOGICAL CHEMISTRY. 275, 33008-33013 (2000).
Hiller, O, Lichte, A, Oberpichler, A, Kocourek, A, and Tschesche, Harald. “Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII”. JOURNAL OF BIOLOGICAL CHEMISTRY 275.42 (2000): 33008-33013.
This data publication is cited in the following publications:
This publication cites the following data publications:

46 Citations in Europe PMC

Data provided by Europe PubMed Central.

Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.
Liao G, Wang Z, Lee E, Moreno S, Abuelnasr O, Baudry M, Bi X., Exp. Neurol. 269(), 2015
PMID: 25864931
Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Sivula M, Hastbacka J, Kuitunen A, Lassila R, Tervahartiala T, Sorsa T, Pettila V., Acta Anaesthesiol Scand 59(2), 2015
PMID: 25329743
Novel osteoinductive photo-cross-linkable chitosan-lactide-fibrinogen hydrogels enhance bone regeneration in critical size segmental bone defects.
Kim S, Bedigrew K, Guda T, Maloney WJ, Park S, Wenke JC, Yang YP., Acta Biomater 10(12), 2014
PMID: 25174669
Expression of modulators of extracellular matrix structure after anterior cruciate ligament injury.
Haslauer CM, Proffen BL, Johnson VM, Murray MM., Wound Repair Regen 22(1), 2014
PMID: 24393158
The multifunctional role of the pallilysin-associated Treponema pallidum protein, Tp0750, in promoting fibrinolysis and extracellular matrix component degradation.
Houston S, Russell S, Hof R, Roberts AK, Cullen P, Irvine K, Smith DS, Borchers CH, Tonkin ML, Boulanger MJ, Cameron CE., Mol. Microbiol. 91(3), 2014
PMID: 24303899
Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.
Heger M, van Golen RF, Broekgaarden M, van den Bos RR, Neumann HA, van Gulik TM, van Gemert MJ., Lasers Med Sci 29(2), 2014
PMID: 24232911
Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into a bovine intervertebral disc organ culture model.
Furtwangler T, Chan SC, Bahrenberg G, Richards PJ, Gantenbein-Ritter B., Spine 38(22), 2013
PMID: 23778376
Expression of MMP-9 in hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
Yu XZ, Ji T, Bai XL, Liang L, Wang LY, Chen W, Liang TB., J Zhejiang Univ Sci B 14(1), 2013
PMID: 23303633
Complement 3 is involved with ventilator-induced lung injury.
Takahashi K, Saha D, Shattino I, Pavlov VI, Stahl GL, Finnegan P, Melo MF., Int. Immunopharmacol. 11(12), 2011
PMID: 21979496
Rapid analysis of matrix metalloproteinase-3 activity by gelatin arrays using a spectral surface plasmon resonance biosensor.
Jung SH, Kong DH, Park JH, Lee ST, Hyun J, Kim YM, Ha KS., Analyst 135(5), 2010
PMID: 20419256
Aldosterone modifies hemostasis via upregulation of the protein-C receptor in human vascular endothelium.
Ducros E, Berthaut A, Mirshahi SS, Faussat AM, Soria J, Agarwal MK, Mirshahi M., Biochem. Biophys. Res. Commun. 373(2), 2008
PMID: 18555797
Do low-molecular-weight heparins influence the healing process in colon anastomosis?
Krzesniak-Wszola N, Bielecki K, Ostrowski J., Colorectal Dis 9(6), 2007
PMID: 17573740
Integrin alphavbeta6 mediates HT29-D4 cell adhesion to MMP-processed fibrinogen in the presence of Mn2+.
Fouchier F, Penel C, Pierre Montero M, Bremond P, Champion S., Eur. J. Cell Biol. 86(3), 2007
PMID: 17275949
Decorin synthesized by arterial smooth muscle cells is retained in fibrin gels and modulates fibrin contraction.
Johnson PY, Potter-Perigo S, Gooden MD, Vernon RB, Wight TN., J. Cell. Biochem. 101(2), 2007
PMID: 17226774
A biodegradable copolymer for the slow release of growth hormone expedites scarring in diabetic rats.
Garcia-Esteo F, Pascual G, Gallardo A, San-Roman J, Bujan J, Bellon JM., J. Biomed. Mater. Res. Part B Appl. Biomater. 81(2), 2007
PMID: 16969827

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 10930399
PubMed | Europe PMC

Search this title in

Google Scholar